SCHIERMEIER ANDREW

CIK 00017384561 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001738456

Recent Transactions

16 trades

Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-03-03+78,750→ 78,750 total
Award
Intellia Therapeutics, Inc.$NTLA
Restricted Stock Unit
2021-03-03+13,125→ 13,125 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-01-05$55.86/sh−1,377→ 16,656 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2020-12-31+4,792→ 18,033 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2020-12-31+9,583→ 9,583 total
Award
Intellia Therapeutics, Inc.$NTLA
Restricted Stock Unit (performance-based)
2020-12-31+4,792→ 4,792 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Restricted Stock Unit (performance-based)
2020-12-31−4,792→ 0 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2020-12-30−1,500→ 148,500 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2020-12-30$13.48/sh+1,500→ 12,673 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (Right to Buy)
2020-03-02+135,000→ 135,000 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (Right to Buy)
2020-01-03+15,000→ 15,000 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (Right to Buy)
2019-08-01+55,000→ 55,000 total
Purchase
Intellia Therapeutics, Inc.$NTLA
Common Stock
2019-03-06$16.00/sh+3,250→ 3,250 total
Purchase
Intellia Therapeutics, Inc.$NTLA
Common Stock
2019-03-06$15.50/sh+4,250→ 7,500 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2018-12-18+81,000→ 81,000 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2018-05-01+23,500→ 23,500 total

Companies

Intellia Therapeutics, Inc.
EVP, Dev and Corp Strategy
$NTLA

Recent Filings

Address

C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET; SUITE 130

CAMBRIDGE, MA, 02139

View on SEC.gov